UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarter ended ~~November~~February 3028, ~~2024~~2025

☐ TRANSITION REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from _________ to ________

Commission file number: ~~333~~000-~~213009~~56678

CANNABIS SUISSE CORP.

(Exact name of registrant as specified in its charter)

Nevada

2600

38-3993849

(State or other jurisdiction of

incorporation or organization)

(Primary Standard Industrial

Classification Code Number)

(I.R.S. Employer

Identification No.)

10 North Newnan Street, Suite A

Jacksonville, FL 32202

Phone: (904) 595 5820

(Address, including zip code, and telephone number,

including area code, of registrant’s principal executive offices)

Indicate by checkmark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer”, “accelerated filer”, “non-accelerated filer”, “emerging growth company” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one).

Large accelerated filer	☐	Accelerated filer	☐
Non-accelerated filer	☒	Smaller reporting company	☒
		Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

As of ~~January~~April 1317, 2025 there were 70,680,938 shares outstanding of the registrant’s common stock.

TABLE OF CONTENTS

PART I - FINANCIAL INFORMATION 1 Item 1. Financial statements. 1 Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations. 1314 Item 3. Quantitative and Qualitative Disclosures about Market Risk. 1516 Item 4. Controls and Procedures. 1517 PART II - OTHER INFORMATION 1718 Item 1. Legal Proceedings. 1718 Item 1A. Risk Factors. 1718 Item 2. Unregistered Sales of Equity Securities and Use of Proceeds. 1718 Item 3. Defaults Upon Senior Securities. 1718 Item 4. Mine Safety Disclosure. 1718 Item 5. Other Information. 1718 Item 6. Exhibits. 1718 SIGNATURES 1819

PART I - FINANCIAL INFORMATION

Item 1. Financial statements.

The accompanying condensed interim financial statements of Cannabis Suisse Corp. (the “Company”) should be read in conjunction with the 10-K that was filed with the United States Securities and Exchange Commission (the “SEC”). The accompanying Condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X. Accordingly, since they are interim statements, the accompanying condensed financial statements do not include all the information and notes required by GAAP for complete financial statement presentation. In the opinion of management, the condensed interim financial statements reflect all adjustments (consisting of normal, recurring adjustments) that are necessary for a fair presentation of the financial position, results of operations, and cash flows for the interim periods presented. Interim results are not necessarily indicative of results for a full year.

In the opinion of management, the condensed financial statements contain all material adjustments, consisting only of normal adjustments considered necessary to present fairly the financial condition, results of operations, and cash flows of the Company for the interim periods presented.

CANNABIS SUISSE CORP.

CONDENSED BALANCE SHEETS

	November 30, 2024		May 31, 2024
	February 28, 2025		May 31, 2024
	(Unaudited)
ASSETS
Current Assets
Cash in Escrow Account	$	~~4,100~~50	$	28,562
Prepaid Expenses		~~130~~117,~~963~~883		167,891
Total Current Assets		~~135~~117,~~063~~933		196,453
Property and Equipment, net		2221,~~490~~429		24,612
Operating Leases Right of Use Assets		~~594~~551,~~294~~745		675,558
TOTAL ASSETS	$	~~751~~691,~~847~~107	$	896,623
LIABILITIES & STOCKHOLDERS’ DEFICIT
Current Liabilities
Accounts Payable	$	2623,~~550~~250	$	4,304
Accrued Interest - Related Parties		2541,~~969~~912		33,380
Advances From Related Parties		-7,400		83,159
Convertible Notes Payable		50,000		50,000
Convertible Notes Payable - Related Party		85,000		85,000
Operating Lease Liabilities - Short-term		91103,~~128~~617		125,157
Total Current Liabilities		~~278~~311,~~647~~179		381,000
Convertible Note Payable - Related Party		2,~~338~~226,~~513~~267		1,820,517
Operating Lease Liabilities - Long-term		~~10,541~~-		40,936
Total Liabilities		2,~~627~~537,~~701~~446		2,242,453
Commitments and Contingencies (Note 5)		-		-
Stockholders’ Deficit
Preferred stock, par value $0.001; 50,000,000 shares authorized, 0 and 5,000,000 shares issued and outstanding as of November 30, 2024 and May 31, 2024, respectively		-		5,000
Preferred stock, par value $0.001; 50,000,000 shares authorized, 0 and 5,000,000 shares issued and outstanding as of February 28, 2025 and May 31, 2024, respectively		-		5,000
Series A Preferred Stock, par value $0.001; 5,000,000 shares authorized, 5,000,000 and 0 issued and outstanding as of November 30, 2024 and May 31, 2024, respectively		5,000		-
Preferred Series A stock, par value $0.001; 5,000,000 shares authorized, 5,000,000 and 0 issued and outstanding as of February 28, 2025 and May 31, 2024, respectively		5,000		-
Common stock, par value $0.001; 1,000,000,000 shares authorized, 70,680,938 shares issued and outstanding as of November 30, 2024 and May 31, 2024, respectively		70,681		70,681
Common stock, par value $0.001; 1,000,000,000 shares authorized, 70,680,938 shares issued and outstanding as of February 28, 2025 and May 31, 2024		70,681		70,681
Additional Paid-In-Capital		1,179,393		1,179,393
Accumulated Deficit		(3,~~130~~101,~~928~~413)		(2,600,904)
Total Stockholders’ Deficit		(1,~~875~~846,~~854~~339)		(1,345,830)
TOTAL LIABILITIES & STOCKHOLDERS’ DEFICIT	$	~~751~~691,~~847~~107	$	896,623

The accompanying notes are an integral part of these condensed unaudited financial statements.

CANNABIS SUISSE CORP.

CONDENSED STATEMENTS OF OPERATIONS

(Unaudited)

	For the three months ended November 30,				For the six months ended November 30,
	For the three months ended				For the nine months ended
	2024		2023		2024		2023
	February 28, 2025		February 29, 2024		February 28, 2025		February 29, 2024
REVENUES
Rental income	$	7,500	$	7,500	$	1522,~~000~~500	$	1522,~~000~~500
Cost of goods sold		7,356		6,~~874~~876		1422,~~712~~068		1320,~~749~~625
Gross Profit		144		~~626~~624		~~288~~432		1,~~251~~875
OPERATING EXPENSES
Professional fees		3610,~~194~~274		2212,~~000~~887		5565,~~273~~547		5466,~~000~~887
Depreciation		1,061		1,061		23,~~122~~183		23,~~122~~183
General and administrative expenses		55,~~198~~597		2849,~~267~~537		~~110~~165,~~041~~638		56105,~~448~~985
TOTAL OPERATING EXPENSES		9266,~~453~~932		5163,~~328~~485		~~167~~234,~~436~~368		~~112~~176,~~570~~055
OPERATING LOSS		(9266,~~309~~788)		(5062,~~702~~861)		(~~167~~233,~~148~~936)		(~~111~~174,~~319~~180)
OTHER INCOME (EXPENSES)
Loss on settlement of debt		-		-		(551,677)		-
Amortization of debt premium		~~113~~112,~~491~~246		-		~~219~~332,~~770~~016		-
Interest expense - related party		(1615,~~120~~943)		(45,~~095~~113)		(3046,~~969~~912)		(813,~~235~~348)
TOTAL OTHER INCOME (EXPENSE)		9796,~~371~~303		(45,~~095~~113)		(~~362~~266,~~876~~573)		(813,~~235~~348)
LOSS BEFORE INCOME TAXES		5,062		(54,797)		(530,024)		(119,554)
INCOME (LOSS) BEFORE INCOME TAXES		29,515		(67,974)		(500,509)		(187,528)
PROVISION FOR INCOME TAXES		-		-		-		-
NET INCOME (LOSS)	$	529,~~062~~515	$	(5467,~~797~~974)	$	(~~530~~500,~~024~~509)	$	(~~119~~187,~~554~~528)
NET LOSS PER SHARE: BASIC	$	0.00	$	(0.00)	$	(0.01)	$	(0.00)
WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING: BASIC		70,680,938		4546,~~837~~254,~~356~~938		70,680,938		45,041,823
NET LOSS PER SHARE: DILUTED	$	0.00	$	(0.00)	$	(0.01)	$	(0.00)
WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING: DILUTED		~~195~~198,~~823~~303,~~835~~589		4546,~~837~~254,~~356~~938		70,680,938		45,041,823

The accompanying notes are an integral part of these condensed unaudited financial statements.

CANNABIS SUISSE CORP.

CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS’ DEFICIT

(Unaudited)

	Series A Preferred Stock			Preferred Stock				Common Stock
	Shares	Amount			Shares	Amount		Shares	Amount		Additional Paid-In- Capital		Unearned Compensation		Accumulated Deficit		Total Stockholders’ Deficit
Balance, May 31, 2023	-	$	-		5,000,000	$	5,000	44,254,938	$	44,255	$	1,055,589	$	(20,000)	$	(1,414,291)	$	(329,447)
Amortization of stock based compensation	-		-		-		-	-		-		-		10,000		-		10,000
Net loss	-		-		-		-	-		-		-		-		(64,757)		(64,757)
Balance, August 31, 2023	-		-		5,000,000		5,000	44,254,938		44,255		1,055,589		(10,000)		(1,479,048)		(384,204)
Cash for common stock	-		-		-		-	2,000,000		2,000		18,000	-	-	-	-		20,000
Amortization of stock based compensation	-		-		-		-	-		-		-		10,000		-		10,000
Net loss	-		-		-		-	-		-		-		-		(54,797)		(54,797)
Balance, November 30, 2023	-		-		5,000,000		5,000	46,254,938		4546,255		1,073,589		-		(1,533,845)		(409,001)
Net loss	-		-		-		-	-		-		-		-		(67,974)		(67,974)
Balance, February 29, 2024	-		-		5,000,000		5,000	46,254,938		46,255		1,073,589		-		1,601,819		(476,975)
Balance, May 31, 2024	-		-		5,000,000		5,000	70,680,938		70,681		1,179,393		-		(2,600,904)		(1,345,830)
Issuance of Series A Preferred Stock to replace previously issued preferred stock	5,000,000		5,000		(5,000,000)		(5,000)	-		-		-		-		-		-
Net loss	-		-		-		-	-		-		-		-		(535,086)		(535,086)
Balance, August 31, 2024	5,000,000		5,000		-		-	70,680,938		70,681		1,179,393		-		(3,135,990)		(1,880,916)
Net income	-		-		-		-	-		-		-		-		5,062		5,062
Balance, November 30, 2024	5,000,000	$	5,000		-	$	-	70,680,938	$	70,681	$	1,179,393	$	-	$	(3,130,928)	$	(1,875,854)
Net income	-		-		-		-	-		-		-		-		29,515		29,515
Balance, February 28, 2025	5,000,000	$	5,000		-	$	-	70,680,938	$	70,681	$	1,179,393	$	-	$	(3,101,413)	$	(1,846,339)

The accompanying notes are an integral part of these condensed unaudited financial statements.

CANNABIS SUISSE CORP.

CONDENSED STATEMENTS OF CASH FLOWS

(Unaudited)

	For the six months ended November 30,
	For the nine months ended
	2024		2023
	February 28, 2025		February 29, 2024
OPERATING ACTIVITIES
Net loss	$	(~~530~~500,~~024~~509)	$	(~~119~~187,~~554~~528)
Adjustments to reconcile net loss to net cash used in operations:
Stock issued for services		-		20,000
Depreciation		23,~~122~~183		23,~~122~~183
Lease cost, net of repayments		86130,~~390~~887		24102,~~950~~264
Loss on settlement of debt		551,677		-
Amortization of debt premium		(~~219~~332,~~770~~016)		-
Changes in assets and liabilities:
Prepaid expenses		3650,~~928~~008		34,~~000~~500
Accounts payable		2218,~~246~~946		(~~1,870~~998)
Accrued interest - related parties		2541,~~969~~912		4913,~~597~~348
Net cash used in Operating Activities		(2435,~~462~~912)		(2145,~~755~~231)
INVESTING ACTIVITIES
Net cash provided (used) by Investing Activities		-		-
FINANCING ACTIVITIES
Advances from related parties		722,~~500~~400		725,~~000~~076
Repayments to related parties		(715,~~500~~000)		-
Proceeds from issuance of stock		-		20,000
Net cash provided by Financing Activities		-7,400		2745,~~000~~076
Net cash increase (decrease) for period		(2428,~~462~~512)		~~5,245~~(155)
Cash at beginning of period		28,562		199
Cash at end of period	$	~~4,100~~50	$	~~5,444~~44
SUPPLEMENTAL
Cash paid for taxes	$	-	$	-
Cash paid for interest	$	-	$	-
Noncash Investing and Financing Information
Related party liabilities extinguished with convertible note payable	$	186,089	$	-
Non-cash promissory convertible note issuance	$	186,089	$	-
Reclass convertible note payable to convertible note payable – related party	$	-	$	85,000

The accompanying notes are an integral part of these condensed unaudited financial statements.

CANNABIS SUISSE CORP.

NOTES TO CONDENSED FINANCIAL STATEMENTS

(Unaudited)

NOTE 1 - ORGANIZATION AND NATURE OF BUSINESS

Cannabis Suisse Corp. (“Company”) was incorporated in the State of Nevada on February 26, 2016. The Company started its real estate business, and in February 2023, the Company leased two properties from companies owned by the CEO and one of them has been subleased out for rental revenue. In February 2024, the Company leased two additional pieces of real properties from companies owned by the CEO for future expansion. See the details of the terms and conditions in Note 9.

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

The summary of significant accounting policies of the Company is presented to assist in understanding the Company’s interim financial statements. The interim financial statements and notes are representations of the Company’s management, who is responsible for integrity and objectivity. These accounting policies conform to accounting principles generally accepted in the United States of America and have been consistently applied in the preparation of the unaudited financial statements.

The financial information furnished herein reflects all adjustments, consisting of normal recurring items that, in the opinion of management, are necessary for a fair presentation of the Company’s financial position, results of operations and cash flows for the interim periods. The results of operations for the ~~six~~nine months ended ~~November~~February 3028, ~~2024~~2025 are not necessarily indicative of the results to be expected for the year ending May 31, 2025.

The information included in this Form 10-Q should be read in conjunction with the Company’s Annual Report on Form 10-K for the year ended May 31, 2024.

Basis of Presentation

The accompanying financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America, (GAAP). The Company’s year-end is May 31.

Use of Estimates

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates.

Cash and Cash Equivalents

The Company considers all highly liquid investments with the original maturities of three months or less to be cash equivalents. The Company had no cash equivalents as of ~~November~~February 3028, ~~2024~~205 and May 31, 2024. The Company had cash in an escrow account of $~~4,100~~50 and $28,562 as of ~~November~~February 3028, ~~2024~~2025 and May 31, 2024, respectively.

Property and equipment

Property and equipment are carried at cost less accumulated depreciation. Depreciation is provided over the assets’ estimated useful lives, using the straight-line method. Estimated useful lives of the plant and equipment are as follows:

Equipment, Furniture and Fixtures

5-10 years

The cost and related accumulated depreciation of assets sold or otherwise retired are eliminated from the accounts and any gain or loss is included in the statements of operations. The cost of maintenance and repairs is charged to the statements of operations as incurred, whereas significant renewals and betterments are capitalized.

Leases

The Company follows the accounting for leases under Accounting Standards Codification (“ASC”) 842 Lease Accounting and determines if an arrangement is a lease or contains a lease at inception. Operating leases result in operating lease right-of-use (“ROU”) assets and operating lease liabilities (short term and long term) being recorded on the Company’s balance sheets.

CANNABIS SUISSE CORP.

NOTES TO CONDENSED FINANCIAL STATEMENTS

(Unaudited)

commencement date based on the present value of lease payments over the lease term. The Company uses the incremental borrowing rate based on the estimated rate of interest for collateralized borrowings over a similar term of the lease payments at commencement date. The operating lease ROU asset also includes any lease payments made and excludes lease incentives. The Company’s lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Lease expense for lease payments is recognized on a straight-line basis over the lease term.

Impairment of Long-Lived Assets

The Company evaluates the impairment of long-lived assets whenever events or changes in circumstances indicate that the carrying amount may not be recoverable. The Company’s evaluation is based on an assessment of potential indicators of impairment, such as an adverse change in the business climate that could affect the value of an asset, current or forecasted operating or cash flow losses that demonstrate continuing losses associated with the use of an asset, and a current expectation that, more likely than not, an asset will be disposed of before the end of its previously estimated useful life. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to future undiscounted net cash flows expected to be generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets. Assets to be disposed of are reported at the lower of the carrying amount or fair value less costs to sell.

During the three and ~~six~~nine months ended ~~November~~February 3028, ~~2024~~2025 and ~~2023~~February 29, 2024, the Company recognized an impairment of long-lived assets in the amount of $0.

Fair Value of Financial Instruments

ASC 820 Fair Value Measurements and Disclosures establishes a three-tier fair value hierarchy, which prioritizes the inputs in measuring fair value. The hierarchy prioritizes the inputs into three levels based on the extent to which inputs used in measuring fair value are observable in the market.

These tiers include:

Level 1:defined as observable inputs such as quoted prices in active markets;

Level 2:defined as inputs other than quoted prices in active markets that are either directly or indirectly observable; and

Level 3:defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions.

The carrying value of the Company’s cash, other current assets, accounts payable, accrued expenses and advances from related parties approximates its fair value due to their short-term maturity.

Income Taxes

The Company accounts for its income taxes in accordance with ASC 740, Income Taxes, which requires recognition of deferred tax assets and liabilities for future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases and tax credits and carry forwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in operations in the period that includes the enactment date.

Rent Revenue Recognition

The Company recognizes rent revenue from the lease of its sub-leased properties in accordance with ASC 842, Leases. The sub-lease is categorized as an operating lease according to ASC criteria for the lease definitions. Rent revenue is recognized on a straight-line basis over the lease term, reflecting the pattern of the economic benefits derived from the lease.

The Company’s leases generally have fixed rental payments over the lease term, with occasional escalations based on predetermined factors. Rent revenue is recognized monthly as the lessor fulfills its obligations under the lease agreement.

CANNABIS SUISSE CORP.

NOTES TO CONDENSED FINANCIAL STATEMENTS

(Unaudited)

Any lease incentives or concessions provided to lessees, such as rent-free periods or tenant improvement allowances, are recognized as a reduction of rent revenue over the lease term.

For the ~~six~~nine months ended ~~November~~February 3028, ~~2024~~2025 and ~~2023~~February 29, 2024, the Company had only one lease arrangement with a single customer and recognized rent revenue of $1522,~~000, respectively~~500. For the three months ended ~~November~~February 3028, ~~2024~~2025 and ~~2023~~February 29, 2024, the Company had rent revenue of $7,500~~, respectively~~.

Cost of Goods Sold

Cost of goods sold includes direct costs of selling items, direct labor cost, rent expense and electricity.

Stock-Based Compensation

The Company accounts for share-based compensation awards in accordance with ASC 718, “Compensation - Stock Compensation”. The cost of services received from employees and non-employees in exchange for awards of equity instruments is recognized in the statement of operations based on the estimated fair value of those awards on the grant date and amortized on a straight-line basis over the requisite service period or vesting period. The Company records forfeitures as they occur.

Basic Income (Loss) Per Share

The Company computes income (loss) per share in accordance with ASC 260, Earnings per Share. Basic loss per share is computed by dividing net income (loss) available to common shareholders by the weighted average number of outstanding common shares during the period. Diluted income (loss) per share gives effect to all dilutive potential common shares outstanding during the period. For the three and ~~six~~nine months ended ~~November~~February 3029, ~~2023~~2024 there were 25,~~375~~384,~~000~~513 potentially dilutive shares that could be issued upon the conversion of the Company’s convertible notes payable and accrued interest and for the ~~six~~nine months ended ~~November~~February 3028, ~~2024~~2025 there were ~~125~~127,~~142~~622,~~897~~651 potentially dilutive shares that could be issued upon the conversion of the Company’s convertible notes payable and accrued interest. These potentially dilutive shares were excluded from the dilutive loss per share calculation because their effect would have been anti-dilutive, therefore basic and diluted net loss per share were the same for those periods.

The following table illustrates the computation of diluted earnings per share for the three months ended ~~November~~February 3028, ~~2024~~2025:

Net income	$	529,~~062~~515
Add: Interest expense on convertible debt		1115,~~120~~943
Net income available to common shareholders (numerator)	$	1645,~~182~~458
Basic weighted average number of common shares outstanding		70,680,938
Dilutive impact of convertible notes and accrued interest		~~125~~127,~~142~~622,~~897~~651
Diluted weighted average number of common shares outstanding (numerator)		~~195~~198,~~823~~303,~~835~~589
Diluted income per common share	$	0.00

Recent Accounting Pronouncements

There have been no recent accounting pronouncements or changes in accounting pronouncements during the quarter ended ~~November~~February 3028, ~~2024~~2025 that are of significance or potential significance to the Company.

NOTE 3 - GOING CONCERN

The accompanying financial statements have been prepared in conformity with GAAP, which contemplate continuation of the Company as a going concern. However, the Company had limited revenues and recurring losses as of ~~November~~February 3028, ~~2024~~2025. The Company has not completed its efforts to establish a stabilized source of revenues sufficient to cover operating costs over an extended period of time. Therefore, there is substantial doubt about the Company’s ability to continue as a going concern.

Management anticipates that the Company will be dependent, for the near future, on additional investment capital to fund operating expenses. The Company intends to position itself so that it will be able to raise additional funds through the capital markets and will rely on related party funding in the meantime. In light of management’s efforts, there are

CANNABIS SUISSE CORP.

NOTES TO CONDENSED FINANCIAL STATEMENTS

(Unaudited)

no assurances that the Company will be successful in this or any of its endeavors or become financially viable and continue as a going concern.

NOTE 4 - PROPERTY AND EQUIPMENT

Property and Equipment:

	November 30, 2024		May 31, 2024
	February 28, 2025		May 31, 2024
Office equipment	$	1,400	$	1,400
Furniture		31,700		31,700
Accumulated depreciation		(1011,~~610~~671)		(8,488)
Net property and equipment	$	2221,~~490~~429	$	24,612

For the three months ended ~~November~~February 3028, ~~2024~~2025 and ~~2023~~February 29, 2024, the Company recognized depreciation expense in the amount of $1,061. For the ~~six~~nine months ended ~~November~~February 3028, ~~2024~~2025 and ~~2023~~February 29, 2024, the Company recognized depreciation expense in the amount of $23,~~122~~183.

NOTE 5 - COMMITMENTS AND CONTINGENCIES

During the normal course of business, the Company may be exposed to litigation. When the Company becomes aware of potential litigation, it evaluates the merits of the case in accordance with ASC 450-20-50, Contingencies. The Company evaluates its exposure to the matter, possible legal or settlement strategies and the likelihood of an unfavorable outcome. If the Company determines that an unfavorable outcome is probable and can be reasonably estimated, it establishes the necessary accruals. As of ~~November~~February 3028, ~~2024~~2025, the Company is not aware of any contingent liabilities that should be reflected in the financial statements.

NOTE 6 - RELATED PARTY TRANSACTIONS

During the ~~six~~nine months ended ~~November~~February 3028, ~~2024~~2025, the president, CEO, and sole director advanced to the Company $722,~~500~~400, was repaid $715,~~500~~000, and $83,159 was settled with a convertible note agreement, see Note 8. During the ~~six~~nine months ended ~~November~~February 3029, ~~2023~~2024, the president, CEO, and sole director advanced to the Company $725,~~000~~076. As of ~~November~~February 3028, ~~2024~~2025 and May 31, 2024, the balances due the related party were $07,400 and $83,159, respectively.

On June 28, 2024, the Company issued a convertible note of $186,089 to Scott McAlister, the Company’s CEO, to pay off the unpaid rent of $69,550, advances of $83,159 and the unpaid interest of $33,380 that the Company owed to Scott McAlister. See Note 8 for terms and conditions.

As of ~~November~~February 3028, ~~2024~~2025 and May 31, 2024, the president, CEO, and sole director was owed $2541,~~969~~912 and $33,380 in accrued interest on convertible notes, respectively.

NOTE 7 - CONVERTIBLE NOTES PAYABLE

On April 1, 2021, Suneetha Nandana Silva Sudusinghe assigned Serhii Cherniienko $60,000 of his loan to Cannabis Suisse Corp. The Agreement contains a provision that allows Serhii Cherniienko to convert the loan to common stock at a fixed price of $0.01 per share. Beneficial conversion feature was $60,000. Of the $60,000, $30,000 was converted to equity in December 2021, and the rest of $30,000 was assigned to Okie LLC. In November 2022, Okie LLC assigned the convertible note to Clifford Koschnick for consideration. As of ~~November~~February 3028, ~~2024~~2025 the balance of the note is $30,000, it is due on demand, and has an interest rate of 0%.

On April 15, 2021, Suneetha Nandana Silva Sudusinghe assigned Noi Tech LLC $30,000 of his loan to Cannabis Suisse Corp. The Agreement contains a provision that allows Noi Tech LLC to convert the loan to common stock at a fixed price of $0.01 per share. Beneficial conversion feature was $30,000. The note was assigned to Okie LLC with a $10,000 discount in May 2022. In November 2022, Okie LLC assigned the convertible note to Clifford Koschnick for consideration. As of ~~November~~February 3028, ~~2024~~2025 the balance of the note is $20,000, it is due on demand, and has an interest rate of 0%.

CANNABIS SUISSE CORP.

NOTES TO CONDENSED FINANCIAL STATEMENTS

(Unaudited)

NOTE 8 - CONVERTIBLE NOTES PAYABLE RELATED PARTIES

In May 2022, Alain Parrik assigned his convertible note of $85,000 the Company owed him to Okie LLC. According to the note terms and conditions, the note can be converted to shares at a fixed price of $0.005 per share. In November 2022, Okie LLC assigned the convertible note to Scott McAlister for consideration. As of ~~November~~February 3028, ~~2024~~2025 the balance of the note is $85,000, it is due on demand, and has an interest rate of 0%.

In November 2022, the Company issued a convertible promissory note in the principal of $135,000 to the Company’s CEO for funds he has advanced the Company for expenses. The Note has a term of four years, the interest rate is 12% and the conversion price is $0.04 per share. As of ~~November~~February 3028, ~~2024~~2025 the balance of the note was $135,000.

In February 20, 2024, the Company issued a convertible promissory note in the amount of $187,852 to 10 N Newnan, LLC, a Company owned by the CEO, for the prepayment of the lease entered in February 2023 for three years from February 2023 to January 2026 for the property at 10 N Newnan Street, Jacksonville, FL 32202. In February 2024, prior to the issuance of the note, the lease was extended for an additional two years to January 2028. The total payments for the remaining four years were $375,704 and the landlord offered a 50% discount for the prepayment, along with a forgiveness of the $93,926 in unpaid rent to that point. The Company issued this note to pay off the lease. The note has a term of four years, the interest rate is 10% per annum and the conversion price is $0.005 per share of common stock. The maturity date is February 20, 2028. The Company recognized the note at its fair value of $1,126,841, the present value of the lease liabilities that were paid off was $297,229, and prepaid interest of $78,476 was recorded, resulting in a loss on settlement of debt of $751,136. The note was issued with a premium of $938,989, which will be amortized over the term of the note. For the ~~six~~nine months ended ~~November~~February 3028, ~~2024~~2025, $~~117~~175,~~615~~458 of note premium was recognized, and the balance of the note was $~~944~~886,~~314~~470 (inclusive of a $~~756~~698,~~462~~618 premium balance) as of ~~November~~February 3028, ~~2024~~2025.

In February 20, 2024, the Company issued a convertible promissory note in the amount of $101,760 to 1268 Church Street, LLC, a Company owned by the CEO, for the prepayment of the lease entered in January 2024 for three years from January 2024 to December 2026 for the property at 1268 Church Street, Jacksonville, FL 32202. In February 2024, prior to the issuance of the note, the lease was extended for an additional two years to December 2028. The total payments for the five years was $203,520, none of which had been paid, and the landlord offered a 50% discount on the unpaid amounts for the prepayment. The Company issued this note to pay off the lease. The note has a term of five years, the interest rate is 10% per annum and the conversion price is $0.005 per share of common stock. The maturity date is February 20, 2029. The Company recognized the note at its fair value of $654,125, the present value the lease liabilities that were paid off was $148,735, and prepaid interest of $48,001 was recorded, resulting in a loss on settlement of debt of $457,389. The note was issued with a premium of $552,365, which would be amortized over the term of the note. During the ~~six~~nine months ended ~~November~~February 3028, ~~2024~~2025, $5582,~~337~~537 of note premium amortization was recognized, and the balance of the note was $~~568~~541,~~262~~052 (inclusive of a $~~466~~439,~~502~~292 premium balance) as of ~~November~~February 3028, ~~2024~~2025.

On June 28, 2024, the Company issued a convertible promissory note in the amount of $186,089 to Scott McAlister, the CEO, to pay off the unpaid rent of $69,550, advances of $83,159 and the unpaid interest of $33,380. The note has a term of five years, the interest rate is 10% per annum and the conversion price is $0.005 per share of common stock. The maturity date is June 28, 2029. The Company recognized the note at its fair value of $737,766. The note was issued with a premium of $551,677, ~~with~~which ~~amortization~~would be amortized over the term of ~~$27,493~~the ~~recognized~~note. ~~during~~During the ~~three~~nine months ended ~~November~~February 3028, ~~2024~~2025, $74,021 of note premium amortization was recognized, and the balance of the note was $~~690~~663,~~937~~745 (inclusive of a $~~504~~477,~~848~~656 premium balance).

As of ~~November~~February 3028, ~~2024~~2025, the maturities of the long-term convertible notes are as follows:

Year ending	Amount
November 30, 2025	$	-
February 28, 2026	$	-
November 30, 2026		-
February 28, 2027		135,000
November 30, 2027		135,000
February 28, 2028		187,852
November 30, 2028		187,852
February 28, 2029		101,760
November 30, 2029		287,849
February 28, 2030		186,089
Total	$	610,701

CANNABIS SUISSE CORP.

NOTES TO CONDENSED FINANCIAL STATEMENTS

(Unaudited)

For the ~~six~~nine months ended ~~November~~February 3028, ~~2024~~2025 and ~~2023~~February 29, 2024, the interest expenses were $3046,~~969~~912 and $813,~~235~~348, respectively.

NOTE 9 - LEASES WITH RELATED PARTIES AND THIRD-PARTIES

In February 2023, the Company signed a lease to rent the office at 10 Newnan Street, Jacksonville, FL 32202, with 10 N Newnan LLC, a related party owned by the Company’s CEO. The lease commencement date was February 1, 2023 and the lease term was thirty-six months. In February 2024, the Company extended the lease for an additional two years and the new maturity date became January 31, 2028. In accordance with ASC 842, the Right-of-Use asset (ROU) and lease liability was remeasured at the modification date to be $297,229 based on a 12% discount rate and a $93,926 gain was recorded as a result of the extension. Following the extension the landlord offered a discount for the prepayment of the lease so in February 2024, the Company prepaid the lease with a convertible note payable (see Note 8) and the prepaid rental interest was recorded for $78,476. As of ~~November~~February 3028, ~~2024~~2025, the balance of the ROU and prepaid rental interest was $~~246~~230,~~436~~186 and $5043,~~997~~765, respectively. During the ~~six~~nine months ended ~~November~~February 3028, ~~2024~~2025 rental expense of $4670,~~964~~446 was recognized related to this lease.

In February 2023, the Company signed a lease to rent the property at 2652 Blanding Blvd, Jacksonville, FL 32210, with 2600 Blanding Blvd., LLC, a related party owned by our CEO. The lease commencement date was February 1, 2023 and the lease term is thirty-six months. Based on the criteria and according to ASC 842, the Right-of-Use asset was $145,341 based on a 12% discount rate, and the lease liability and lease commitment was also the same amount. The monthly base rental payment is $5,000, with additional monthly direct costs of $350; with incentives of free-rent for the first three months, and the Company has the option to pay all or a portion of the rent in shares of its common stock. As of ~~November~~February 3028, ~~2024~~2025, the balance of the ROU was $6350,~~328~~563 and no monthly payments had been made on the lease, therefore the lease liability was $101,670. During the ~~six~~nine months ended ~~November~~February 3028, ~~2024~~2025 rental expense of $2944,~~424~~139 was recognized related to this lease, of which $1422,~~712~~069 was allocated to cost of sales for the portion of the property that was subleased.

In January 2024, the Company signed a lease to rent the property at 1268 Church Street, Jacksonville, FL 32202, with 1268 Church Street LLC, a related party owned by the Company’s CEO. The lease commencement date was January 1, 2024 and the lease term was 37 months. In accordance with ASC 842 the Right-of-Use asset and lease liability was originally recorded for $104,472 based on a 12% discount rate. In February 2024, the Company extended the lease for almost three years and the new maturity date became December 31, 2028. In accordance with ASC 842, the Right-of-Use asset (ROU) and lease liability was remeasured at the modification date to be $148,735 based on a 12% discount rate and a $6,784 gain was recorded as a result of the extension. Following the extension, the landlord offered a discount for the prepayment of the lease and the Company made the prepayment for the lease by issuing a convertible promissory note (see Note 8) and prepaid rental interest was recorded for $48,001. As of ~~November~~February 3028, ~~2024~~2025, the balance of the ROU and prepaid rental interest was $~~130~~124,~~891~~579 and $3531,~~317~~453, respectively. During the ~~six~~nine months ended ~~November~~February 3028, ~~2024~~2025 rental expense of $2030,~~352~~528 was recognized related to this lease.

In February 2024, the Company signed a lease to rent the property at 2502 Blanding Blvd, Jacksonville, FL 32210, with 2600 Blanding Blvd LLC, a related party owned by the Company’s CEO. The lease commencement date was February 1, 2024 and the lease term is sixty months. In accordance with ASC 842 the Right-of-Use asset and lease liability was recorded for $176,213 based on a 12% discount rate. The landlord offered a discount for the prepayment of the lease so the Company made the prepayment for the lease by issuing a convertible promissory note (see Note 8) and prepaid rental interest was recorded for $58,973. As of ~~November~~February 3028, ~~2024~~2025, the balance of the ROU and prepaid rental interest was $~~153~~146,~~639~~417 and $4237,~~349,~~811 respectively. During the ~~six~~nine months ended ~~November~~February 3028, ~~2024~~2025 rental expense of $2335,~~518~~277 was recognized related to this lease.

In February 2023, the Company signed a sub-lease as the lessor to rent a portion of the property at 2652 Blanding Blvd to a third-party private company. The monthly rent was $2,500 which will bring rental revenue of $30,000 annually. The term of the sub-lease was one year from February 2023 to January 2024 and the subtenant was not entitled to exercise any options to extend or renew the term of the lease. The sub-lease is currently on a month-by-month term.

The total lease expenses for the ~~six~~nine months ended ~~November~~February 3028, ~~2024~~2025 were $~~120~~180,~~258~~387, including $1422,~~712~~068 recorded as cost of sales and $~~105~~158,~~545~~319 recorded in general and administrative expenses in the statements of operations. The total ~~lease expenses for the six months ended November 30, 2023 were $66,313, including $13,749 recorded as cost of sales and $52,564 in general and administrative expenses in the statements of operations.~~

CANNABIS SUISSE CORP.

NOTES TO CONDENSED FINANCIAL STATEMENTS

(Unaudited)

~~The~~lease ~~Company’s~~expenses ~~weighted~~for ~~average~~the ~~remaining~~nine ~~lease~~months ~~term~~ended isFebruary ~~3.42~~29, ~~years~~2024 ~~and~~were ~~weighted~~$102,264, ~~average~~including ~~discount~~$20,626 ~~rate~~recorded isas ~~12%.~~cost ~~The~~of ~~following~~sales ~~table~~and ~~summarizes~~$81,639 ~~the presentation~~ in ~~the~~general ~~Company’s~~and ~~balance~~administrative ~~sheet~~expenses ofin ~~its~~the ~~operating~~statements ~~leases~~of operations.

	As of November 30, 2024		As of May 31, 2024
Assets
Right-of-Use	$	594,294	$	675,558
Liabilities
Lease liabilities - Short-term	$	91,128	$	125,157
Lease liabilities - Long-term		10,541		40,936
Total operating lease liabilities	$	101,669	$	166,093

The Company’s weighted average remaining lease term is 3.21 years and weighted average discount rate is 12%. The following table summarizes the presentation in the Company’s balance sheet of its operating leases.

Future minimum lease payments as of November 30, 2024:

	As of February 28, 2025		As of May 31, 2024
Assets
Right-of-Use	$	551,745	$	675,558

Liabilities
Lease liabilities - Short-term	$	103,617	$	125,157
Lease liabilities - Long-term		-		40,936
Total operating lease liabilities	$	103,617	$	166,093

Lease commitments
Dec 2024 - Nov 2025	$	96,300
Dec 2025 - Nov 2026		10,700
Dec 2026 - Nov 2027		-
Dec 2027 - Nov 2028		-
Dec 2028 - Nov 2029		-
Total undiscounted lease payments		107,000
Imputed interest		(5,331)
Total operating lease liabilities	$	101,669

NOTE 10 - STOCKHOLDERS’ EQUITY

Preferred Stock

The Company is authorized to issue 50,000,000 shares of preferred stock with a par value of $0.001.

On March 17, 2021, the Board of Directors, along with the majority stockholder, resolved that the 5,000,000 preferred shares with voting rights of 1 to 10 shall be issued to Suneetha Nandana Silva Sudusinghe in exchange for 5,000,000 common shares that Suneetha Nandana Silva Sudusinghe owned previously. The 5,000,000 preferred shares were issued on July 21, 2021. The stock was transferred to Scott McAlister through a stock purchase agreement in May 2022.

On July 2, 2024 the Company filed a Certificate of Designation, Preferences, and Rights with the State of Nevada to authorize the issuance of up to 5,000,000 shares of Series A Preferred Stock. The holders of the Series A Preferred Stock are not entitled to receive any dividends and the holders are not entitled to receive any assets of the Company available for distribution to its stockholders upon any liquidation, dissolution, or winding up of the corporation. Each Series A Preferred Stock share is entitled to votes equal to 10 shares of common stock.

On July 7, 2024, the Company issued 5,000,000 shares of Series A Preferred Stock to our CEO. The shares of Series A Preferred Stock were issued in replacement for the same number of shares of preferred stock he received when he purchased the stock from the prior CEO, as it was determined the prior issuance of the shares of preferred stock was deficient in that the proper state filing to include the certificate of rights and preferences was not made for the original issuance.

As of ~~November~~February 3028, ~~2024~~2025, the Company had 5,000,000 shares of Preferred A stock issued and outstanding.

Common Stock

The Company is authorized to issue 1,000,000,000 shares of common stock with a par value of $0.001.

On January 11, 2023, the Company issued 3,600,000 restricted shares of common stock at $0.04 per share to a consultant for services. The value of the 3,600,000 shares of common stock issued was $144,400, of which $124,000 was earned as of May 31, 2023 and the remaining $20,000 was earned during the year ended May 31, 2024.

In September 2023, the Company’s CEO paid $20,000 to the Company for 2,000,000 shares of common stock at a price of $0.01 per share.

As of February 28, 2025, the Company had 70,680,938 shares of common stock issued and outstanding.

CANNABIS SUISSE CORP.

NOTES TO CONDENSED FINANCIAL STATEMENTS

(Unaudited)

Common Stock

The Company is authorized to issue 1,000,000,000 shares of common stock with a par value of $0.001.

In September 2023, the Company’s CEO paid $20,000 to the Company for 2,000,000 shares of common stock at a price of $0.01 per share.

During the three and six months ended November 30, 2024 there were no issuances of common stock.

As of November 30, 2024, the Company had 70,680,938 shares of common stock issued and outstanding.

NOTE 11 - SUBSEQUENT EVENTS

In accordance with SFAS 165 (ASC 855), Subsequent Events, the Company has analyzed its operations subsequent to ~~November~~February 3028, ~~2024~~2025, to the date these financial statements were issued, and has determined that it does not have any material subsequent events except the following:

During the period from ~~December~~March 1, ~~2024~~2025, to the date the financial statements were issued, the Company’s CEO advanced $710,000 to fund the Company’s operations.

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

This quarterly report and other reports filed by Cannabis Suisse Corp. (Formerly Geant Corp.) (“we,” “us,” “our,” or the “Company”), from time to time contain or may contain forward-looking statements and information that are based upon beliefs of, and information currently available to, the Company’s management as well as estimates and assumptions made by Company’s management. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. When used in the filings, the words “anticipate”, “believe”, “estimate”, “expect”, “future”, “intend”, “plan” or the negative of these terms and similar expressions as they relate to the Company or the Company’s management identify forward-looking statements. Such statements reflect the current view of the Company with respect to future events and are subject to risks, uncertainties, assumptions, and other factors. Should one or more of these risks or uncertainties materialize, or should the underlying assumptions prove incorrect, actual results may differ significantly from those anticipated, believed, estimated, expected, intended, or planned.

Our financial statements are prepared in accordance with accounting principles generally accepted in the United States (“GAAP”). These accounting principles require us to make certain estimates, judgments, and assumptions. We believe that the estimates, judgments, and assumptions upon which we rely are reasonable based upon information available to us at the time that these estimates, judgments, and assumptions are made. These estimates, judgments, and assumptions can affect the reported amounts of assets and liabilities as of the date of the financial statements as well as the reported amounts of revenues and expenses during the periods presented. Our financial statements would be affected to the extent there are material differences between these estimates.

In General

Since June 2022, the Company has focused its efforts on real estate operations. We have no involvement in any aspect of the cannabis industry. In February 2023, we leased a commercial building from a company controlled by our CEO and subleased a portion of the building to a third party. The term of the sublease was one year and the annual rent was $30,000. Effective March of 2024, the sublease became a month-to-month lease for $2,500 per month.

Results of Operations for the three and ~~six~~nine months ended ~~November~~February 3028, ~~2024~~2025 and ~~2023~~February 29, 2024

Revenue and Cost of Sales

For the three and ~~six~~nine months ended ~~November~~February 3028, ~~2024~~2025, the Company generated total revenue of $7,500 and $1522,~~000~~500, respectively, from renting. The cost of sales for the three and ~~six~~nine months ended ~~November~~February 3028, ~~2024~~2025, were $7,356 and $1422,~~712~~068, respectively.

For the three and ~~six~~nine months ended ~~November~~February 3029, ~~2023~~2024, the Company generated total revenue of $7,500 and $1522,~~000~~500, respectively. The cost of sales for the three and ~~six~~nine months ended ~~November~~February 3029, ~~2023~~2024, were $6,~~874~~877 and $1320,~~749~~616, respectively.

The revenue and costs for both periods were almost the same reflecting the rent revenue and cost of sales that were ~~align~~aligned with the sublease.

Operating Expenses

Total operating expenses for the three and ~~six~~nine months ended ~~November~~February 3028, ~~2024~~2025, were $9266,~~453~~932 and $~~167~~234,~~436~~368, respectively. The operating expenses for the ~~six~~nine months ended ~~November~~February 3028, ~~2024~~2025, included professional fees of $5565,~~273~~547; depreciation expense of $23,~~122~~183 and general and administrative expenses of $~~110~~165,~~041~~638. The operating expenses for the three months ended ~~November~~February 3028, ~~2024~~2025, included professional fees of $3610,~~194~~274; depreciation expense of $1,061 and general and administrative expenses of $55,~~198~~597.

Total operating expenses for the three and ~~six~~nine months ended ~~November~~February 3029, ~~2023~~2024, were $5163,~~328~~485 and $~~112~~176,~~570~~055, respectively. The operating expenses for the ~~six~~nine months ended ~~November~~February 3029, ~~2023~~2024, included professional fees of $5466,~~000~~887; depreciation expense of $23,~~122~~183 and general and administrative expenses of $56105,~~448~~985. The operating expenses for the three months ended ~~November~~February 3029, ~~2023~~2024, included professional fees of $2212,~~000~~887; depreciation expense of $1,061 and general and administrative expenses of $2849,~~267~~537.

The increase in operating expenses is related to the increase of the rental expenses as more rental properties were leased by the Company in January and February of 2024.

Other Income (Expense)

The total other income (expense) for the three months ended ~~November~~February 3028, ~~2024~~2025 and ~~2023~~February 29, 2024 were $9796,~~371~~303 and $(45,~~095~~113), respectively. The other expenses for the three months ended ~~November~~February 3028, ~~2024~~2025, contained interest ~~expenses~~expense - related party of $1615,~~120~~943, and the gain of $~~113~~112,~~491~~246 on the amortization of debt premium, while for the three months ended ~~November~~February 3029, ~~2023~~2024, the other expenses contained only interest ~~expenses~~expense - related party of $45,~~095~~113. The significant increase in other income is due to the gain on the amortization of the debt premium.

The total other income (expense) for the ~~six~~nine months ended ~~November~~February 3028, ~~2024~~2025 and ~~2023~~February 29, 2024 were $(~~362~~266,~~876~~573) and $(813,~~235~~348), respectively. The other expenses for the ~~six~~nine months ended ~~November~~February 3028, ~~2024~~2025, contained interest ~~expenses~~expense - related party of $3046,~~969~~912, loss of $551,677 on the settlement of debt, gain of $~~219~~332,~~770~~016 on the amortization of debt premium, while for the ~~six~~nine months ended ~~November~~February 3029, ~~2023~~2024, the other expenses contained only interest ~~expenses~~expense - related party of $813,~~235~~348. The significant increase in other expenses is due to the loss on settlement of debt resulting from the convertible note paying for the unpaid rent, related party advances and unpaid interest owed to the related party.

Net ~~Income~~income (Loss)

The net income (loss) for the three months ended ~~November~~February 3028, ~~2024~~2025 and ~~2023~~February 29, 2024 was $529,~~062~~515 and $(5467,~~797~~974), respectively. The net income (loss) for the ~~six~~nine months ended ~~November~~February 3028, ~~2024~~2025 and ~~2023~~February 29, 2024 was $(~~530~~500,~~024~~509) and $(~~119~~187,~~554~~528), respectively.

Liquidity and Capital Resources and Cash Requirements

As of ~~November~~February 3028, ~~2024~~2025, the Company had cash of $~~4,100~~50. Furthermore, the Company had a working capital deficit of $~~143~~193,~~584~~246.

During the ~~six~~nine months ended ~~November~~February 3028, ~~2024~~2025, the Company used $2435,~~462~~912 of cash in operating activities due to its net loss of $~~530~~500,~~024~~509 plus its amortization of debt premium of $~~219~~332,~~770~~016; offset by depreciation of $23,~~122~~183, lease cost (net) of $86130,~~390~~887, loss on settlement of debt of $551,677, decrease in prepaid expenses of $3650,~~928~~008, an increase in accounts payable of $2218,~~246~~946 and an increase in accrued ~~expenses~~interest - related party of $2541,~~969~~912.

During the ~~six~~nine months ended ~~November~~February 3029, ~~2023~~2024, the Company used $2145,~~755~~231 of cash in operating activities due to its net loss of $~~119~~187,~~554 plus a decrease in accounts payable of $1,870~~528; offset by depreciation of $23,~~122~~183, stock payment for services of $20,000, lease cost (net) of $24102,~~950~~264, decrease in prepaid expenses of $34,~~000~~500, decrease in accounts payable of $998, and an increase in accrued interest - related party of $4913,~~597~~348.

During the ~~six~~nine months ended ~~November~~February 3028, ~~2024~~2025 and ~~2023~~February 29, 2024 the Company did not have cash in investing activities.

During the ~~six~~nine months ended ~~November~~February 3028, ~~2024~~2025, the Company generated $7,~~500~~400 of cash in financing activities, which came for advances of $22,400 from a related party offset by repayments of $715,~~500~~000 to a related party ~~in financing activities~~.

During the ~~six~~nine months ended ~~November~~February 3029, ~~2023~~2024, the Company generated $2745,~~000~~076 of cash in financing activities, which came from advances of $725,~~000~~076 from athe related party and $20,000 proceeds from the issuance of common stock.

In its audited financial statements as of May 31, 2024, the Company was issued a “going concern” opinion, meaning that there is substantial doubt we can continue as an on-going business for the next twelve months unless we obtain additional capital. Our sources for cash at this time are investments by others, loans and advances from our CEO who is our sole director, and very limited revenue from renting. We must raise cash to implement our plan and stay in business.

Off-Balance Sheet Arrangements

The Company does not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on the Company’s financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources.

Critical Accounting Policies

Use of Estimates

Leases

ROU assets represent the right to use an underlying asset for the lease term and lease liabilities represent the obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. The Company uses the incremental borrowing rate based on the estimated rate of interest for collateralized borrowings over a similar term of the lease payments at commencement date. The operating lease ROU asset also includes any lease payments made and excludes lease incentives. The Company’s lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Lease expense for lease payments is recognized on a straight-line basis over the lease term.

Rent Revenue Recognition

Any lease incentives or concessions provided to lessees, such as rent-free periods or tenant improvement allowances, are recognized as a reduction of rent revenue over the lease term.

Recent Accounting Pronouncements

There have been no recent accounting pronouncements or changes in accounting pronouncements during the ~~six~~nine months ended ~~November~~February 3028, ~~2024~~2025, that are of significance or potential significance to the Company.

Item 3. Quantitative and Qualitative Disclosures about Market Risk.

As a “smaller reporting company” as defined by Item 10 of Regulation S-K, we are not required to provide information required by this Item.

Item 4. Controls and Procedures.

Disclosure Controls and Procedures

We maintain disclosure controls and procedures, as defined in Rule 13a‐15(e) promulgated under the Securities Exchange Act of 1934 (the “Exchange Act”), that are designed to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure.

16We carried out an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of our disclosure controls and procedures as of February 28, 2025. Based on the evaluation of these disclosure controls and procedures, and in light of the material weaknesses found in our internal controls over financial reporting, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were not effective.

WeA ~~carried~~material ~~out~~weakness anis ~~evaluation~~a deficiency, ~~under~~or ~~the~~combination ~~supervision~~of ~~and~~deficiencies, ~~with~~in ~~the~~internal ~~participation~~control ofover ~~our~~financial ~~management~~reporting, ~~including~~such ~~our~~that ~~Chief~~there ~~Executive~~is ~~Officer~~a ~~and~~reasonable ~~Chief~~possibility ~~Financial~~that ~~Officer,~~a material misstatement of the ~~effectiveness~~Company’s ofannual ~~our~~or ~~disclosure~~interim ~~controls~~financial ~~and~~statements ~~procedures~~will asnot ofbe ~~November~~prevented ~~30,~~or ~~2024.~~detected ~~Based~~ on ~~the~~a ~~evaluation~~timely ofbasis. ~~these~~In ~~disclosure~~its ~~controls~~assessment ~~and procedures, and in light~~ of the ~~material~~effectiveness ~~weaknesses~~of ~~found in our~~ internal ~~controls~~control over financial reporting, ~~our~~as ~~Chief~~of ~~Executive~~February ~~Officer~~28, ~~and~~2025, ~~Chief~~the ~~Financial~~Company ~~Officer~~determined ~~concluded~~ that ~~our~~there ~~disclosure~~were ~~controls~~control ~~and~~deficiencies ~~procedures~~that ~~were~~constituted ~~not~~material ~~effective~~weaknesses, as described below.

A material weakness is a deficiency, or combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the Company’s annual or interim financial statements will not be prevented or detected on a timely basis. In its assessment of the effectiveness of internal control over financial reporting as of November 30, 2024, the Company determined that there were control deficiencies that constituted material weaknesses, as described below.

1.We do not have an adequate control environment or proper corporate governance - We have no risk assessment, information or communication, or monitoring processes in place and have no policies that require formal written approval for related party transactions. Additionally, the Board of Directors does not operate independently of management. Also, while not being legally obligated to have an audit committee, it is the management’s view that such a committee, including a financial expert member, is an utmost important entity level control over the Company’s financial statements. Currently the Board of Directors acts in the capacity of the Audit Committee, and does not include a member that is considered to be independent of management to provide the necessary oversight over management’s activities.

2.We do not maintain appropriate internal controls - We do not have formal accounting policies and procedures and have not maintained sufficient internal controls over financial reporting. We lack segregation of duties or adequate levels of supervision and review and there are limited accounting resources with the appropriate knowledge of U.S. generally accepted accounting principles or SEC experience to ensure the financial reporting is free from material misstatements.

3.We do not have appropriate information technology controls - We retain copies of all financial data and material agreements; however, there is no formal procedure or evidence of normal backup of the Company’s data or off-site storage of data in the event of theft, misplacement, or loss due to unmitigated factors.

Accordingly, the Company concluded that these control deficiencies resulted in a reasonable possibility that a material misstatement of the annual or interim financial statements will not be prevented or detected on a timely basis by the company’s internal controls.

As a result of the material weaknesses described above, management has concluded that the Company did not maintain effective internal control over financial reporting as of ~~November~~February 3028, ~~2024~~2025, based on criteria established in Internal Control- Integrated Framework issued by COSO-2013.

Changes in Internal Controls over Financial Reporting

There has been no change in our internal control over financial reporting occurred during our third fiscal quarter that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

PART II - OTHER INFORMATION

Item 1. Legal Proceedings.

We know of no legal proceedings to which we are a party or to which any of our property is the subject which are pending, threatened or contemplated or any unsatisfied judgments against us.

Item 1A. Risk Factors.

As a “smaller reporting company” as defined by Item 10 of Regulation S-K, we are not required to provide information required by this Item.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

None.

Item 3. Defaults Upon Senior Securities.

None.

Item 4. Mine Safety Disclosure.

Not applicable to our Company.

Item 5. Other Information.

During the quarter ended ~~November~~February 3028, ~~2024~~2025, no director or officer of the Company adopted or terminated a “rule 10b5-1 trading arrangement” or “non-Rule 10b-5 trading arrangement” as such terms are defined in Item 408(a) of Regulation S-K.

Item 6. Exhibits.

The following exhibits are included as part of this report by reference:

Exhibit
Number		Exhibit Description

31.1		Certification pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2		Certification pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1		Certification. pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2		Certification. pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS		Inline XBRL Instance Document
101.SCH		Inline XBRL Taxonomy Extension Schema Document
101.CAL		Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF		Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB		Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE		Inline XBRL Taxonomy Extension Presentation Linkbase Document
104		Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

SIGNATURES

In accordance with Section 13 or 15(d) of the Exchange Act, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized on ~~January~~April 1317, 2025.

	CANNABIS SUISSE CORP.

	By:	/s/ Scott McAlister
	Name:	Scott McAlister
	Title:	Chief Executive Officer, Chief Financial Officer. (Principal Executive, Financial and Accounting Officer)

In accordance with the Exchange Act, this report has been signed by the following person on behalf of the registrant in the capacities and on the date indicated.

April 17, 2025

By: /s/ Scott McAlister

Name Scott McAlister

Chief Executive Officer, Chief Financial Offer (principal accounting officer)

Filing Compare · CANNABIS SUISSE CORP.